Wells Fargo & Company MN Raises Stock Holdings in Maximus, Inc. (NYSE:MMS)

Wells Fargo & Company MN boosted its holdings in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 36.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 34,148 shares of the health services provider's stock after buying an additional 9,055 shares during the period. Wells Fargo & Company MN owned approximately 0.06% of Maximus worth $2,549,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Barclays PLC grew its stake in Maximus by 285.1% during the 3rd quarter. Barclays PLC now owns 170,971 shares of the health services provider's stock valued at $15,927,000 after purchasing an additional 126,573 shares during the last quarter. Virtu Financial LLC purchased a new stake in Maximus in the third quarter valued at approximately $319,000. World Investment Advisors LLC increased its holdings in Maximus by 6.6% in the 3rd quarter. World Investment Advisors LLC now owns 5,289 shares of the health services provider's stock worth $493,000 after buying an additional 326 shares during the period. Wilmington Savings Fund Society FSB raised its position in Maximus by 3.3% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 66,805 shares of the health services provider's stock worth $6,224,000 after buying an additional 2,164 shares during the last quarter. Finally, Tidal Investments LLC lifted its stake in Maximus by 49.1% during the 3rd quarter. Tidal Investments LLC now owns 20,674 shares of the health services provider's stock valued at $1,926,000 after acquiring an additional 6,809 shares during the period. 97.21% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. Raymond James raised shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 target price for the company in a report on Thursday, January 2nd. StockNews.com cut Maximus from a "buy" rating to a "hold" rating in a report on Friday, February 14th.

Insider Activity

In other Maximus news, Director Jan Madsen sold 2,439 shares of the business's stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the sale, the director now directly owns 18,097 shares in the company, valued at $1,225,347.87. This represents a 11.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the sale, the insider now owns 2,512 shares in the company, valued at approximately $171,167.68. This trade represents a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company's stock.

Maximus Price Performance

Maximus stock traded down $1.08 during trading on Friday, reaching $67.72. The company had a trading volume of 324,726 shares, compared to its average volume of 553,643. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. The firm's 50-day simple moving average is $67.65 and its 200 day simple moving average is $74.40. The firm has a market capitalization of $3.83 billion, a PE ratio of 14.56 and a beta of 0.68. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last announced its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. As a group, equities research analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be given a $0.30 dividend. The ex-dividend date is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.77%. Maximus's dividend payout ratio is currently 25.81%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.